Primecap Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,000
Closed -$5.22K 340
2022
Q4
$5.22K Sell
12,000
-3,600
-23% -$1.57K ﹤0.01% 334
2022
Q3
$4K Sell
15,600
-1,100
-7% -$282 ﹤0.01% 335
2022
Q2
$6K Sell
16,700
-1,600
-9% -$575 ﹤0.01% 341
2022
Q1
$12K Sell
18,300
-1,800
-9% -$1.18K ﹤0.01% 339
2021
Q4
$26K Sell
20,100
-31,700
-61% -$41K ﹤0.01% 342
2021
Q3
$112K Sell
51,800
-525
-1% -$1.14K ﹤0.01% 337
2021
Q2
$143K Hold
52,325
﹤0.01% 333
2021
Q1
$137K Sell
52,325
-300
-0.6% -$785 ﹤0.01% 327
2020
Q4
$146K Sell
52,625
-600
-1% -$1.67K ﹤0.01% 319
2020
Q3
$246K Sell
53,225
-1,900
-3% -$8.78K ﹤0.01% 309
2020
Q2
$155K Sell
55,125
-18,700
-25% -$52.6K ﹤0.01% 306
2020
Q1
$180K Sell
73,825
-46,600
-39% -$114K ﹤0.01% 290
2019
Q4
$617K Sell
120,425
-2,862
-2% -$14.7K ﹤0.01% 288
2019
Q3
$796K Sell
123,287
-1,000
-0.8% -$6.46K ﹤0.01% 286
2019
Q2
$774K Sell
124,287
-7,251
-6% -$45.2K ﹤0.01% 291
2019
Q1
$1.4M Sell
131,538
-662
-0.5% -$7.05K ﹤0.01% 277
2018
Q4
$1.05M Sell
132,200
-3,163
-2% -$25.2K ﹤0.01% 281
2018
Q3
$2.62M Hold
135,363
﹤0.01% 279
2018
Q2
$2.45M Sell
135,363
-12,675
-9% -$229K ﹤0.01% 269
2018
Q1
$1.58M Sell
148,038
-172,875
-54% -$1.84M ﹤0.01% 273
2017
Q4
$13.5M Sell
320,913
-105,437
-25% -$4.45M 0.01% 225
2017
Q3
$23.5M Buy
426,350
+9,200
+2% +$506K 0.02% 200
2017
Q2
$77.4M Buy
417,150
+57,284
+16% +$10.6M 0.07% 153
2017
Q1
$43M Buy
359,866
+269,928
+300% +$32.3M 0.04% 176
2016
Q4
$8.94M Sell
89,938
-2,662
-3% -$264K 0.01% 229
2016
Q3
$10.4M Hold
92,600
0.01% 223
2016
Q2
$9.51M Sell
92,600
-2,525
-3% -$259K 0.01% 224
2016
Q1
$8.74M Sell
95,125
-963
-1% -$88.4K 0.01% 225
2015
Q4
$13.9M Sell
96,088
-662
-0.7% -$95.5K 0.01% 209
2015
Q3
$10M Buy
96,750
+34,250
+55% +$3.54M 0.01% 219
2015
Q2
$10.2M Buy
+62,500
New +$10.2M 0.01% 220